Fig. 2.
Changes of the activation (G/Gmax) and the steady-state inactivation (availability) curves by glycosylation inhibition with tunicamycin, and their parameters of half-activation potentials (V1/2-activation) and half-inactivation potentials (V1/2-inactivation). Both curves were obtained by Boltzmann fittings with data when cells were incubated with vehicle or tunicamycin (10−2g/l) for 1 h (a), 6 h (b), 12 h (c), or 24 h (d). The number of cells is indicated in parentheses. Values represent the mean ± SE. *p < 0.01 vs. vehicle